Different EGF-induced receptor dimer conformations for signaling and internalization

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Epidermal Growth Factor Receptor (EGFR) activation and internalization mechanisms are crucial for cancer therapy but remain debated.
• Understanding whether agonists form EGFR dimers or act on pre-existing dimers is key.

Purpose of the Study:

• To provide direct evidence for EGF-induced EGFR dimer formation.
• To investigate the effect of tyrosine kinase (TK) inhibitors on EGFR dimerization and internalization.
• To determine the role of intracellular TK dimer conformation in EGFR internalization.

Main Methods:

• Utilized Förster Resonance Energy Transfer (FRET) between snap-tagged EGFR subunits to quantify dimer formation.
• Assessed the impact of EGF and various TK inhibitors (Erlotinib, Lapatinib) on EGFR dimerization.
• Monitored EGF-induced EGFR internalization in the presence of TK inhibitors.

Main Results:

• EGF agonists significantly increase EGFR dimer formation, confirmed by FRET.
• Erlotinib-class TK inhibitors induce EGFR dimer formation even when the binding domain is inactive.
• TK inhibitors block EGFR signaling but do not inhibit EGF-induced internalization; only Erlotinib promoting asymmetric dimers slowed internalization.

Conclusions:

• EGFR internalization is primarily regulated by the conformation of the intracellular TK dimer, not EGFR signaling.
• Distinct modes of action exist for TK inhibitors targeting EGFR.
• These findings open new avenues for controlling EGFR signaling in cancer treatment.